In Posey et al.’s study, CAR T cells targeting the MUC1 Tn glycoform demonstrated significant efficacy against adenocarcinoma, effectively controlling tumor growth and specifically targeting abnormal MUC1 glycosylation in multiple cancer types (124). This evidence concerns the gene MUC1 and neoplasm.